Physician profile
Adeel I Khan
NPI 1790993863
$316,111.38
in general payments reported to CMS, 2019-2025
43 companies · $28K in 2025
The $28K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78K · 2020: $18K · 2021: $50K · 2022: $27K · 2023: $63K · 2024: $51K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $128K · Travel and Lodging: $7,322 · Food and Beverage: $7,053 · Education: $103 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $128,212.50 |
| Travel and Lodging | $7,321.87 |
| Food and Beverage | $7,053.08 |
| Education | $102.81 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $294,674.14 | 2019-2025 | Arexvy, Nucala, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $5,724.93 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Mylan Specialty L.P. | $5,434.81 | 2019-2024 | Yupelri |
| Intuitive Surgical, INC. | $3,772.43 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $2,249.73 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Viiv Healthcare Company | $600.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $382.11 | 2021-2025 | Dupixent |
| Electromed, INC. | $313.50 | 2021-2025 | Smartvest |
| Jazz Pharmaceuticals INC. | $228.66 | 2019-2025 | Xywav |
| Genzyme Corporation | $222.22 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $217.80 | 2019-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $199.67 | 2021-2024 | Tyvaso |
| Grifols USA, LLC | $194.46 | 2021-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $178.80 | 2022-2025 | Wakix |
| Medtronic USA, INC. | $175.00 | 2019 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $148.85 | 2023-2024 | Inspire |
| Genentech USA, INC. | $146.87 | 2019 | |
| Ani Pharmaceuticals, INC. | $144.87 | 2023-2025 | Purified Cortrophin Gel |
| Sunovion Pharmaceuticals INC. | $134.22 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $130.51 | 2020-2025 | Glassia |
| Insmed, INC. | $104.30 | 2021-2024 | Arikayce |
| Philips North America LLC | $100.86 | 2019-2024 | (8874) Incourage |
| Avadel Cns Pharmaceuticals, LLC | $85.05 | 2024-2025 | Lumryz |
| Fisher & Paykel Healthcare INC | $59.93 | 2020-2025 | Fisher & Paykel Healthcare |
| Amgen INC. | $57.99 | 2023-2025 | Tezspire, Tavneos |
| Baxter Healthcare | $57.23 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Veloxis Pharmaceuticals, INC. | $50.00 | 2023 | Envarsus |
| Merck Sharp & Dohme LLC | $42.08 | 2021-2023 | |
| Resmed Corp | $34.39 | 2021-2023 | |
| Ambu INC. | $33.68 | 2021 | |
| Conmed Corporation | $25.30 | 2024 | Airseal |
| Ethicon US, LLC | $22.29 | 2024 | Vistaseal, Surgicel Nu-Knit, Harmonic |
| Pulmonx Corporation | $21.29 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Shire North American Group INC | $19.03 | 2019 | |
| Lilly USA, LLC | $17.45 | 2025 | Zepbound |
| Tactile Systems Technology INC | $16.87 | 2024 | Entre Plus, Flexitouch Plus |
| Paratek Pharmaceuticals, INC. | $16.80 | 2023 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $14.23 | 2022 | |
| Pfizer INC. | $13.57 | 2021 | |
| Novartis Pharmaceuticals Corporation | $12.64 | 2021 | |
| Circassia INC. | $11.96 | 2019 | |
| Veran Medical Technologies, INC. | $11.17 | 2019-2020 | |
| Itamar Medical INC | $9.69 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adeel Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.